Orbus Therapeutics
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Total Raised
$71MInvestors Count
6Deal Terms
2Orbus Therapeutics Funding, Orbus Therapeutics Valuation & Orbus Therapeutics Revenue
4 Fundings
Orbus Therapeutics's latest funding round was a Series A - IV for $10M on October 22, 2020.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/22/2020 | Series A - IV | $10M | 1 | |||
8/11/2020 | Series A - III | |||||
8/15/2017 | Series A - II | |||||
8/19/2015 | Series A |
Date | 10/22/2020 | 8/11/2020 | 8/15/2017 | 8/19/2015 |
|---|---|---|---|---|
Round | Series A - IV | Series A - III | Series A - II | Series A |
Amount | $10M | |||
Investors | ||||
Valuation | ||||
Revenue | ||||
Sources | 1 |
Orbus Therapeutics Deal Terms
2 Deal Terms
Orbus Therapeutics's deal structure is available for 2 funding rounds, including their Series A - II from August 15, 2017.
Round | Series A - II | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A - II | |||||||||||||||
Series A |
Orbus Therapeutics Investors
6 Investors
Orbus Therapeutics has 6 investors. Longitude Capital invested in Orbus Therapeutics's Series A - IV funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
8/19/2015 | 10/22/2020 | 4 Series A, Series A - II (2017), Series A - III (2020), Series A - IV (2020) | Venture Capital | California | ||
Venture Capital | Florida | |||||
Private Equity | Illinois | |||||
Venture Capital | United Kingdom | |||||
Venture Capital | North Carolina |
First funding | 8/19/2015 | ||||
|---|---|---|---|---|---|
Last Funding | 10/22/2020 | ||||
Investor | |||||
Rounds | 4 Series A, Series A - II (2017), Series A - III (2020), Series A - IV (2020) | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Private Equity | Venture Capital | Venture Capital |
Location | California | Florida | Illinois | United Kingdom | North Carolina |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.